AviadoBio’s Post

❓Fecal incontinence is a condition that is hugely prevalent, yet underreported and stigmatized. 📄 In this article, together with colleagues from ttopstart and the AMELIE project, we hoped to raise awareness and highlight the potential of cell therapy as a potential alternative to the current therapeutic options. 👉🏼To read the full article, you can follow the link in the post below.

📄 New whitepaper in the Journal of Cell and Gene Therapy Insights highlights the overlooked burden of faecal incontinence (FI) and proposes cell therapy as a transformative solution. The paper discusses the potential of cell therapy to provide a minimally invasive, curative option compared to current treatments. The AMELIE project, supported by CVBF, is a notable initiative in this field. For more details, access the open-access paper. #CellTherapy #MedicalResearch #FaecalIncontinence #AMELIE 

The article I wrote in collaboration with my colleagues from ttopstart and the AMELIE consortium is now published in Cell & Gene Therapy Insights! Here we discuss how regenerative medicine can be used to treat faecal incontinence.

How can the latest cell therapy technologies be harnessed to treat faecal incontinence? Read our newly published article, free to read in the Cell and Gene Therapy Insights journal: https://lnkd.in/ee_aNQYp #faecalincontinence #regenerativemedicine #celltherapy

We will attend the virtual #partnering Oct 17-18 at Alliance for Regenerative Medicine, #CGMesa23! Annogen plays a specific role in providing its SuRE™ #humanpromoters (cell specific and/or inducible) and AIM™ #integrationmapping for cell engineering (e.g. #allogeneic platforms) Looking forward to connecting with senior executives and top stakeholders to tackle the most pressing issues in cell and gene therapies.   Learn more: https://lnkd.in/eiUpMy4   

"Recent years have seen a translational evolution in #genetherapy from state-of-the-art sciences to #patient care. With the marketing approval of Hemgenix, an adeno-associated virus vector-based gene #therapy for the treatment of adults with Hemophilia B, it heralds of a new age of gene therapy." As gene therapies continue to evolve, KCR Chief Medical Officer, Dr. Anna Baran and Principal Consultant, Dave Li, explain how they arrived to the market and the challenges that still lie ahead. Check it out! #KCRCRO #ClinicalTrials #ClinicalResearch #Innovation #WhitePaper #GeneTherapy

🧠 Bridging the Gap in Global Health: Cell & Gene Therapy Access in LMICs Exciting advancements in cell and gene therapies (CGTs) promise revolutionary treatments for a myriad of diseases. However, their accessibility remains a challenge, especially in low- and middle-income countries (LMICs). Our recent study introduces an adaptable 'hub and spoke' model tailored to enhance CGT delivery in these regions, with case studies from Brazil and the MENA region. This model aims to improve equitable access to these lifesaving therapies and foster international collaborations to overcome healthcare disparities. Discover the full insights in our latest publication. 🔗 https://lnkd.in/ejF_wdq6 #GlobalHealth #GeneTherapy #CellTherapy #HealthcareInnovation #LMICs #HealthEquity

Discover the potential of cell and gene therapies to offer patients suffering from incurable diseases, such as Parkinson's, a new perspective in the latest episode of Bayer's "Headlines of the Future" podcast. Hear why this could be a revolutionary form of treatment for patients with Parkinson's: https://lnkd.in/eMMSehfe #MedicalInnovation #TeamBayer

Discovering the future of medicine: Germany's cell & gene therapy market 2023-2028 Germany is leading the charge in gene therapies at the forefront of oncological advancements, mainly targeting rare diseases from preclinical stages through pre-registration. 🔗 Want to delve deeper into the trends and data? Check out https://bit.ly/4b4C8Ea #germanycellandgenetherapymarket #cellandgenetherapymarket #focusreportsbyarizton #ariztonresearchreveals #marketresearch #researchreport #marketinsights #markettrends #marketsize #marketshare #marketgrowth #marketforecast #marketexpansion #healthcareandlifesciences

On #RareDiseaseDay, we look at the transformative potential of gene therapy for rare diseases and the critical role of accurate information in empowering clinicians to advance health equity for these unique patient populations. 
Read the blog